Loading
A phase 2 trial of bevacizumab (glioblastoma use), capecitabine, fOLFOX (5-FU, leucovorin, oxaliplatin) and sintilimab in colorectal cancer, run by Fujian Cancer Hospital, not yet recruiting.
PULSAR Combined With PD-1 Ab and Chemotherapy Plus Bev. for CRLM is a phase 2, interventional study registered as NCT06788171 by Fujian Cancer Hospital, with a registry enrolment figure of 35 participants, started 2025-03-01 and due to reach its primary completion in 2026-12-01. Interventions recorded: Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy; Bevacizumab; Capecitabine; Oxaliplatin; Sintilimab. Conditions listed: Colorectal Cancer Liver Metastasis. Primary outcome: Progression-free-Survival. Colorectal eligibility wording from the registry: "Pathologically confirmed colorectal cancer with liver metastases (stage M1)". Sites: China. No results are recorded here; the registry entry is the source.
Shares Sintilimab, Bevacizumab (glioblastoma use), FOLFOX (5-FU, leucovorin, oxaliplatin), Capecitabine and the tag colorectal-deep-dive.
Shares Bevacizumab (glioblastoma use), FOLFOX (5-FU, leucovorin, oxaliplatin), Capecitabine, Platinum agents and the tag colorectal-deep-dive.
Shares Bevacizumab (glioblastoma use), FOLFOX (5-FU, leucovorin, oxaliplatin), Capecitabine, Platinum agents and the tag colorectal-deep-dive.
Shares Sintilimab, FOLFOX (5-FU, leucovorin, oxaliplatin), Capecitabine, Platinum agents and the tag colorectal-deep-dive.
Shares Sintilimab, FOLFOX (5-FU, leucovorin, oxaliplatin), Capecitabine, Platinum agents and the tag colorectal-deep-dive.
Shares FOLFOX (5-FU, leucovorin, oxaliplatin), Capecitabine, Platinum agents, Colon cancer (adenocarcinoma of the colon) and the tag colorectal-deep-dive.
Shares FOLFOX (5-FU, leucovorin, oxaliplatin), Capecitabine, Platinum agents, Colon cancer (adenocarcinoma of the colon) and the tag colorectal-deep-dive.
Shares FOLFOX (5-FU, leucovorin, oxaliplatin), Capecitabine, Platinum agents, Colon cancer (adenocarcinoma of the colon) and the tag colorectal-deep-dive.